“Glaucoma’s Significant Economic Burden in Finland: €202 Million in Additional Annual Direct Costs and €71 Million in Indirect Costs”

https://pubmed.ncbi.nlm.nih.gov/38117760

The economic burden of glaucoma in Finland is significant, with additional annual direct and indirect costs of €202 million and €71 million, respectively, due to increased health care consumption and productivity losses mainly from non-eye-related health care and co-morbidities.